ArriVent BioPharma Inc. C...
25.27
0.42 (1.69%)
At close: Jan 15, 2025, 1:47 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21
Cash & Equivalents 150.39M 163.37M 37.28M
Short-Term Investments n/a n/a n/a
Long-Term Investments n/a n/a 2.00K
Other Long-Term Assets 2.84M 72.00K 87.00K
Receivables 761.00K 500.00K 250.00K
Inventory -240.00K n/a n/a
Other Current Assets 9.06M 156.00K 29.00K
Total Current Assets 159.97M 182.62M 42.95M
Property-Plant & Equipment 291.00K 139.00K n/a
Goodwill & Intangibles n/a n/a n/a
Total Long-Term Assets 3.13M 211.00K 89.00K
Total Assets 163.10M 182.83M 43.04M
Account Payables 4.53M 3.09M 293.00K
Deferred Revenue n/a -1 n/a
Short-Term Debt 140.00K 128.00K n/a
Other Current Liabilities 6.95M 5.14M 1.52M
Total Current Liabilities 11.62M 8.36M 1.82M
Long-Term Debt 177.00K 11.00K n/a
Other Long-Term Liabilities n/a n/a n/a
Total Long-Term Liabilities 177.00K 11.00K n/a
Total Liabilities 11.80M 8.37M 1.82M
Total Debt 317.00K 139.00K n/a
Common Stock n/a 4.00K 4.00K
Retained Earnings -157.84M -88.51M -51.61M
Comprehensive Income n/a -4.00K -4.00K
Shareholders Equity 151.30M 174.46M 41.22M
Total Investments n/a n/a 2.00K